Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
16
Number of overlapping holdings
27.1%
% of RSPH's 59 holdings also in WDNA
19.0%
% of WDNA's 90 holdings also in RSPH
Overlap by Weight
Sector Drift (RSPH minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in RSPH |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 1.8% | 1.8% | 1.8% |
|
ELI LILLY & CO | 1.7% | 2.7% | 1.7% |
|
GILEAD SCIENCES INC | 1.6% | 1.9% | 1.6% |
|
AMGEN INC | 1.6% | 1.7% | 1.6% |
|
LABCORP HOLDINGS | 1.8% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
RSPH Overweight Relative to WDNA
|
CARDINAL HEALTH INC | 2.1% |
|
DEXCOM INC | 2.0% |
|
CENCORA INC | 2.0% |
|
IDEXX LABORATORIES INC | 2.0% |
|
HCA HOLDINGS INC | 1.9% |
|
MCKESSON CORP | 1.9% |
|
EDWARDS LIFESCIENCES CORP | 1.9% |
|
ALIGN TECHNOLOGY INC | 1.9% |
|
RESMED INC | 1.9% |
|
BOSTON SCIENTIFIC CORP | 1.9% |
RSPH Underweight Relative to WDNA
|
NATERA INC | -3.7% |
|
TWIST BIOSCIENCE CORP. | -3.3% |
 |
NOVOZYMES A/S-B SHARES | -2.9% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
VERICEL CORPORATION | -2.6% |
|
BRIDGEBIO PHARMA, INC. | -2.4% |
|
VERACYTE INC | -2.1% |
|
AGIOS PHARMACEUTICALS INC | -1.9% |
|
UNITED THERAPEUTICS CORP | -1.7% |
 |
NOVARTIS AG | -1.7% |